Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6602469 ◽

2005 ◽

Vol 92 (6) ◽

pp. 1013-1018 ◽

Author(s):

K H Yeh ◽

Y S Lu ◽

C H Hsu ◽

J F Lin ◽

H J Chao ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

High Dose ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Abstract CT101: Final results of a randomized Phase II study of PD 0332991, a cyclin-dependent kinase (CDK)-4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1; TRIO-18)

10.1158/1538-7445.am2014-ct101 ◽

2014 ◽

Author(s):

Richard S. Finn ◽

John P. Crown ◽

Istvan Lang ◽

Katalin Boer ◽

Igor M. Bondarenko ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

Cyclin Dependent Kinase ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

A multicenter phase II study of docetaxel, gemcitabine and trastuzumab administration as first-line treatment in patients with advanced breast cancer (ABC) overexpressing HER-

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.728 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 728-728 ◽

Author(s):

A. Polyzos ◽

D. Mavroudis ◽

J. Boukovinas ◽

E. Tsiakopoulos ◽

N. Malamos ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

Letrozole (LE)-Vinorelbine (VIN) as first-line treatment in advanced breast cancer (ABC) patients: Preliminary results of a multicentre phase II study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)90855-5 ◽

2004 ◽

Vol 2 (3) ◽

pp. 129

Author(s):

S Barni ◽

P Colina ◽

S Leo ◽

P Sandri ◽

A Savarino ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

Multicentre Phase ◽

Preliminary Results ◽

First Line Treatment

Download Full-text

A multicenter phase II study of docetaxel, gemcitabine and trastuzumab administration as first-line treatment in patients with advanced breast cancer (ABC) overexpressing HER-

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.728 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 728-728 ◽

Author(s):

A. Polyzos ◽

D. Mavroudis ◽

J. Boukovinas ◽

E. Tsiakopoulos ◽

N. Malamos ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

Phase II study of an oral combination of doxifluridine, prednimustine and idarubicin (FUPRIDA) for first line treatment of advanced breast cancer

Annals of Oncology ◽

10.1093/oxfordjournals.annonc.a058524 ◽

1993 ◽

Vol 4 (5) ◽

pp. 423-425 ◽

Author(s):

P. Alberto

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study

Cancer Science ◽

10.1111/cas.13507 ◽

2018 ◽

Vol 109 (3) ◽

pp. 803-813 ◽

Author(s):

Norikazu Masuda ◽

Reiki Nishimura ◽

Masato Takahashi ◽

Kenichi Inoue ◽

Shinji Ohno ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

First Line Treatment

Download Full-text

Taxol (T) and mitoxantrone (M) as first line treatment in advanced breast cancer (ABC) patients. A phase II study of the Southern Italy oncology group (GOIM)

European Journal of Cancer ◽

10.1016/s0959-8049(97)85282-3 ◽

1997 ◽

Vol 33 ◽

pp. S155

Author(s):

F. Giotta ◽

L. Manzione ◽

V. Gebbia ◽

D. Bilancia ◽

N. Gebbia ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Southern Italy ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

Oncology Group ◽

First Line Treatment

Download Full-text

EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer

Breast Cancer Research ◽

10.1186/s13058-020-01319-1 ◽

2020 ◽

Vol 22 (1) ◽

Author(s):

Laura Biganzoli ◽

Saverio Cinieri ◽

Rossana Berardi ◽

Rebecca Pedersini ◽

Amelia McCartney ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Older Women ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Line Treatment ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: Report of the Clinical Screening Group of the EORTC

Annals of Oncology ◽

10.1093/oxfordjournals.annonc.a010544 ◽

1996 ◽

Vol 7 (2) ◽

pp. 165-171 ◽

Author(s):

P. Fumoleau ◽

B. Chevallier ◽

P. Kerbrat ◽

Y. Krakowski ◽

J.-L. Misset ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

Efficacy And Safety ◽

Clinical Screening ◽

Multicentre Phase ◽

First Line Treatment

Download Full-text

Final Results of a Phase II Trial Evaluating Trastuzumab and Bevacizumab as First Line Treatment of HER2-Amplified Advanced Breast Cancer.

10.1158/0008-5472.sabcs-09-6094 ◽

2009 ◽

Author(s):

S. Hurvitz ◽

M. Pegram ◽

L. Lin ◽

D. Chan ◽

H. Allen ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Breast ◽

Line Treatment ◽

First Line Treatment

Download Full-text